METTL3 and lung adenocarcinoma: Further, M2-TAMs can promote lung adenocarcinoma immuno-resistance by enhancing METTL3-mediated m6A methylation (107), as well as inducing oxaliplatin resistance by increasing METTL3 in colorectal cancer cells (108).